Professor Vincent Racaniello, a BioCrowd co-founder and virologist who studies the pathogenesis of polio and influenza viruses commented that there will likely be two influenza vaccines offered this fall: a trivalent vaccine consisting of seasonal H3N2 and H1N1 strains and an influenza B strain; and a monovalent one consisting of the 2009 pandemic H1N1 strain.
He posited an interesting question to BioCrowd members earlier today: "Will you be receiving a flu vaccine this fall, and if so, which one?"
To weigh in on the topic and find out which vaccines makes sense for you, check out Professor Racaniello’s influenza vaccine survey and discussion at BioCrowd!
Until next time...
No hay comentarios:
Publicar un comentario